Joachim Bartels

Joachim Bartels

Auto-generated profile, based on publicly available information

Joachim Bartels

Department of Dermatology, Faculty of Medicine, University of Kiel, Kiel, Germany

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JHJürgen Harder
Jürgen Harder
JBJoachim Bartels
Joachim Bartels
ECEnno Christophers
Enno Christophers
JSJens-Michael Schröder
Jens-Michael Schröder
The growing public health problem of infections caused by multiresistant Gram-positive bacteria, in particularStaphylococcus aureus, prompted us to screen human epithelia for endogenous S. aureus-killing factors. A novel 5-kDa, nonhemolytic antimicrobial peptide (human β-defensin-3, hBD-3) was isolated from human lesional psoriatic scales and cloned from keratinocytes. hBD-3 demonstrated a salt-insensitive broad spectrum of potent antimicrobial activity against many potentially pathogenic microbes including multiresistant S. aureus and vancomycin-resistant Enterococcus faecium. Ultrastructural analyses of hBD-3-treated S. aureusrevealed signs of cell wall perforation. Recombinant hBD-3 (expressed as a His-Tag-fusion protein in Escherichia coli) and chemically synthesized hBD-3 were indistinguishable from naturally occurring peptide with respect to their antimicrobial activity and biochemical properties. Investigation of different tissues revealed skin and tonsils to be major hBD-3 mRNA-expressing tissues. Molecular cloning and biochemical analyses of antimicrobial peptides in cell culture supernatants revealed keratinocytes and airway epithelial cells as cellular sources of hBD-3. Tumor necrosis factor α and contact with bacteria were found to induce hBD-3 mRNA expression. hBD-3 therefore might be important in the innate epithelial defense of infections by various microorganisms seen in skin and lung, such as cystic fibrosis.

26 June 1997 in Nature
Verified
Journal Article
Closed access
PDF file
JHJ. Harder
J. Harder
JBJ. Bartels
J. Bartels
ECE Christophers
E Christophers
JSJ.-M. Schröder
J.-M. Schröder

28 November 2004 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RGRegine Gläser
Regine Gläser
JHJürgen Harder
Jürgen Harder
HLHans Lange
Hans Lange
JBJoachim Bartels
Joachim Bartels
ECEnno Christophers
Enno Christophers
JSJens-Michael Schröder
Jens-Michael Schröder

1 June 2000 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
JHJürgen Harder
Jürgen Harder
UMUlf Meyer-Hoffert
Ulf Meyer-Hoffert
LTLuis Manuel Teran
Luis Manuel Teran
LSLars Schwichtenberg
Lars Schwichtenberg
JBJoachim Bartels
Joachim Bartels
JSJens-Michael Schröder
Jens-Michael Schröder
Cultured lung epithelial cells release antibacterial activity upon contact with Pseudomonas aeruginosa (PA), which is impaired in cystic fibrosis (CF). In order to identify the factors responsible for killing PA by a biochemical approach, we purified antimicrobial activity from supernatants of the A549 lung epithelial cell line, previously stimulated with PA bacteria, by subsequent high performance liquid chromatography. NH2-terminal sequencing of a major bactericidal compound revealed it to be identical with human beta-defensin-2 (hBD-2). A mucoid phenotype of PA, but not two nonmucoid PA strains, high concentrations (> 10 μ g/ml) of PA lipopolysaccharide, tumor necrosis factor α, and interleukin (IL)-1 β, but not IL-6, dose-dependently induced hBD-2 messenger RNA in cultured normal bronchial, tracheal, as well as normal and CF-derived nasal epithelial cells. Genomic analysis of hBD-2 revealed a promoter region containing several putative transcription factor binding sites, including nuclear factor (NF) κ B, activator protein (AP)-1, AP-2, and NF-IL-6, known to be involved in the regulation of inflammatory responses. Thus, hBD-2 represents a major inducible antimicrobial factor released by airway epithelial cells either on contact with mucoid PA or by endogenously produced primary cytokines. Therefore, it might be important in lung infections caused by mucoid PA, including those seen in patients with CF.

1 April 2009 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
TBThomas Bosch
Thomas Bosch
RARené Augustin
René Augustin
FAFriederike Anton-Erxleben
Friederike Anton-Erxleben
SFSebastian Fraune
Sebastian Fraune
GHGeorg Hemmrich
Georg Hemmrich
JSJens-M. Schröder
Jens-M. Schröder

1 January 1998 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MMMitsuru Mochizuki
Mitsuru Mochizuki
JBJoachim Bartels
Joachim Bartels
AMAntony I Mallet
Antony I Mallet
ECEnno Christophers
Enno Christophers
JSJens-M. Schröder
Jens-M. Schröder
A common feature of some parasitic infections and allergic and atopic skin diseases is the involvement of Th2 lymphocytes and the dermal appearance of eosinophils (Eos). Because Th2 lymphocytes apparently do not release Eo attractants, we addressed the question of whether the Th2 cytokine IL-4 induces its production in dermal fibroblasts. We therefore stimulated fibroblasts with IL-4. HPLC investigation of supernatants revealed a single Eo chemotactic protein, which was purified to homogeneity giving a single 13-kDa band upon SDS-PAGE analyses. Peptide mapping with subsequent amino acid sequencing revealed an Eo-selective chemotaxin, which consists of a mixture of N-terminally truncated and O-glycosylated forms of the chemokine eotaxin. Other chemokines such as RANTES, MCP-3, MCP-4, or MIP-1α were not detected as Eo chemotaxins under these conditions. Using reverse transcriptase-PCR techniques, we found that IL-4 dose and time dependently induces eotaxin mRNA in dermal fibroblasts. Stimulation with IL-4 and TNF-α caused a 10- to 20-fold increase of the release of three biochemically different eotaxin forms, each consisting of a mixture of N-terminally truncated and O-glycosylated variants having the same backbone amino acid sequence but different specific activities. Our findings support the hypothesis that eosinophil recruitment seen in IL-4-mediated skin reactions, at least in part, may be due to Th2 cytokine-mediated induction of eotaxin in dermal fibroblasts.